Allurion Technologies (ALURD) EBT Margin (2022 - 2026)
Allurion Technologies' (ALURD) quarterly EBT Margin came in at 206.07% in Q1 2026, down 18088.0% YoY from N/an in Q1 2025, and down 13.58% on a QoQ basis from 181.43% in Q4 2025.
Allurion Technologies (ALURD) EBT Margin (2022 - 2026) Analysis & Trends
Allurion Technologies (ALURD) has 5 years of EBT Margin data on file, last reported at 206.07% in Q1 2026.
- Quarterly EBT Margin fell 18088.0% year-over-year to 206.07% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 268.28% (down 23310.0% YoY) and the FY2025 annual result came in at 191.25%, down 17107.0% from the prior year.
- EBT Margin slipped to 206.07% in Q1 2026, from 181.43% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 164.06% in Q3 2024 to a low of 446.76% in Q3 2025.
- A 5-year average of 127.38% and a median of 122.46% in 2023 frame the typical range for EBT Margin.
- Annual changes were most pronounced in 2024 — EBT Margin soared 28272 bps — and 2025, when it plunged 61082 bps.
- Tracing ALURD's EBT Margin over 5 years: stood at 67.59% in 2022, then plunged by 281 bps to 257.63% in 2023, then surged by 37 bps to 162.76% in 2024, then declined by 11 bps to 181.43% in 2025, then retreated by 14 bps to 206.07% in 2026.
- The last three EBT Margin figures came in at 206.07% (Q1 2026), 181.43% (Q4 2025), and 446.76% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.61 Bn | 194.01 Bn | 7.27 Bn | 12.10% |
| 2 | Stryker | 127.81 Bn | 124.34 Bn | 4.50 Bn | 23.74% |
| 3 | Medtronic | 119.04 Bn | 109.82 Bn | 6.41 Bn | 18.70% |
| 4 | Boston Scientific | 73.68 Bn | 73.14 Bn | 3.85 Bn | 19.48% |
| 5 | Edwards Lifesciences | 51.96 Bn | 47.71 Bn | 1.35 Bn | 29.86% |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn | 24.27% |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | 13.09% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 8.91% |
| 9 | Steris | 23.06 Bn | 22.58 Bn | 684.20 Mn | 18.32% |
| 10 | Allurion Technologies | 49.18 Mn | 44.13 Mn | 1.23 Mn | -206.07% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -206.07% |
| Dec 31, 2025 | -181.43% |
| Sep 30, 2025 | -446.76% |
| Jun 30, 2025 | -274.99% |
| Mar 31, 2025 | -25.20% |
| Dec 31, 2024 | -162.76% |
| Sep 30, 2024 | 164.06% |
| Jun 30, 2024 | -70.18% |
| Mar 31, 2024 | 22.08% |
| Dec 31, 2023 | -257.63% |
| Sep 30, 2023 | -118.66% |
| Jun 30, 2023 | -169.55% |
| Mar 31, 2023 | -126.27% |
| Dec 31, 2022 | -67.59% |
| Sep 30, 2022 | -83.90% |
| Jun 30, 2022 | -33.26% |